Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-18

Misfolded SOD1 Toxicity in Amyotrophic Lateral Sclerosis

Objective

Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease characterized by the loss of upper and lower motor neurons. The reason for the degeneration of motor neurons in ALS is still unknown. Mitochondria have been implicated as a possible target for toxicity by several studies reporting a range of dysfunctions and the toxic binding of misfolded SOD1 to mitochondrial targets. However, the mechanism by which mutant SOD1 associates with mitochondria specifically from affected tissues is still unknown. Preliminary data show that a cytosolic factor in unaffected tissues is responsible for preventing the accumulation of misfolded SOD1. This factor was identified as the macrophage migration inhibitory factor (MIF). MIF inhibits the association of mutant SOD1 with mitochondria and accumulation of misfolded SOD1. The hypothesis of this proposal is that MIF is reduced in abundance or inactive as a chaperone within the CNS, leading to increased accumulation of misfolded SOD1 and neurodegeneration. This proposal aims to unambiguously determine how toxicity is caused by misfolded SOD1 accumulation and finally an attempt to rescue these toxic effects in models of ALS will be done. The specific aims are (1) Determination of the tissue specificity of misfolded SOD1 accumulation and mitochondrial association and characterization of MIF activity as a chaperone for misfolded SOD1; (2) Determination of how mitochondrial association of misfolded SOD1 affects mitochondrial function in the spinal cord of mutant SOD1 animals; and (3) Determination of whether increased synthesis or depletion of MIF affects misfolded mutant SOD1 accumulation and pathogenesis in mice. The proposed study has the potential to yield important information about misfolded SOD1 toxicity mechanisms. Moreover, the characterization of MIF as a novel chaperone for misfolded SOD1 opens new avenues for the development of ALS therapies.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP7-PEOPLE-2012-CIG
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

MC-CIG - Support for training and career development of researcher (CIG)

Coordinator

BEN-GURION UNIVERSITY OF THE NEGEV
EU contribution
€ 100 000,00
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0